Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2003

01-09-2003

Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation

Authors: Paolo Aretini, Emma D'Andrea, Barbara Pasini, Alessandra Viel, Renato Mariani Costantini, Laura Cortesi, Enrico Ricevuto, Simona Agata, Roberta Bisegna, Mauro Boiocchi, Maria Adelaide Caligo, Luigi Chieco-Bianchi, Giovanna Cipollini, Rosella Crucianelli, Cristina D'Amico, Massimo Federico, Chiara Ghimenti, Clelia De Giacomi, Arcangela De Nicolo, Lara Della Puppa, Sergio Ferrari, Corrado Ficorella, Davide Iandolo, Siranoush Manoukian, Paolo Marchetti, Fabio Marroni, Chiara Menin, Marco Montagna, Laura Ottini, Valeria Pensotti, Marco Pierotti, Paolo Radice, Manuela Santarosa, Vittorio Silingardi, Daniela Turchetti, Generoso Bevilacqua, Silvano Presciuttini

Published in: Breast Cancer Research and Treatment | Issue 1/2003

Login to get access
Metadata
Title
Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation
Authors
Paolo Aretini
Emma D'Andrea
Barbara Pasini
Alessandra Viel
Renato Mariani Costantini
Laura Cortesi
Enrico Ricevuto
Simona Agata
Roberta Bisegna
Mauro Boiocchi
Maria Adelaide Caligo
Luigi Chieco-Bianchi
Giovanna Cipollini
Rosella Crucianelli
Cristina D'Amico
Massimo Federico
Chiara Ghimenti
Clelia De Giacomi
Arcangela De Nicolo
Lara Della Puppa
Sergio Ferrari
Corrado Ficorella
Davide Iandolo
Siranoush Manoukian
Paolo Marchetti
Fabio Marroni
Chiara Menin
Marco Montagna
Laura Ottini
Valeria Pensotti
Marco Pierotti
Paolo Radice
Manuela Santarosa
Vittorio Silingardi
Daniela Turchetti
Generoso Bevilacqua
Silvano Presciuttini
Publication date
01-09-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1025428807472

Other articles of this Issue 1/2003

Breast Cancer Research and Treatment 1/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine